Lilly Provides Update on Strategy and Announces 2015 Financial Guidance

–Eli Lilly and Company today announced its 2015 financial guidance and outlined plans to grow revenue and expand margins through the balance of the decade. “We are successfully moving from a challenging period of patent expirations to a period of resumed growth, led by diabetes, oncology and animal health,” said John C. Lechleiter, Ph.D., Lilly’s chairman, president…